SCHEMBL17775320

SCHEMBL17775320

CCCN1C(=O)c2ccc3c4c(ccc(c24)C1=O)C(=O)N(C)C3=O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TERT O14746 7/20 0.56
▸ MEN1 O00255 6/20 0.52
▸ KMT2A Q03164 6/20 0.52
▸ ALDH1A1 P00352 4/20 0.52
▸ RAB9A P51151 2/20 0.52
▸ KDM4E B2RXH2 2/20 0.52
▸ RGS12 O14924 2/20 0.52
▸ HTT P42858 2/20 0.52
▸ RECQL P46063 2/20 0.52
▸ NPC1 O15118 1/20 0.52
▸ LMNA P02545 1/20 0.52
▸ PABPC1 P11940 1/20 0.52
▸ SMN1; SMN2 Q16637 1/20 0.52
▸ MAPK1 P28482 3/20 0.50
▸ L3MBTL1 Q9Y468 3/20 0.50
▸ STAT3 P40763 1/20 0.47
▸ HIF1A Q16665 1/20 0.47
▸ PIN1 Q13526 1/20 0.46
▸ PIN4 Q9Y237 1/20 0.46
▸ HPGD P15428 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18470164 0.87 TERT (0.51) TERTMEN1KMT2AALDH1A1RAB9A
SCHEMBL8680446 0.86 TERT (0.67) TERTMEN1KMT2AALDH1A1RAB9A
SCHEMBL21081429 0.86 TERT (0.61) TERTMEN1KMT2AALDH1A1RAB9A
SCHEMBL12175676 0.86 CYP1B1 (0.58) TERTMEN1KMT2AALDH1A1RAB9A
SCHEMBL18470159 0.85 KDM4E (0.62) TERTMEN1KMT2AALDH1A1RAB9A
SCHEMBL17775318 0.83 TERT (0.51) TERTMEN1KMT2AALDH1A1RAB9A
SCHEMBL13395590 0.83 TERT (0.51) TERTMEN1KMT2AALDH1A1RAB9A
SCHEMBL127059 0.82 MEN1 (0.55) TERTMEN1KMT2AALDH1A1RAB9A
SCHEMBL30937815 0.82 MEN1 (0.55) TERTMEN1KMT2AALDH1A1RAB9A
SCHEMBL25989152 0.82 KDM4E (0.65) TERTMEN1KMT2AALDH1A1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10316060-B2 Energy transfer within pi-conjugated peptide heterostructures in aqueous environments THE JOHNS HOPKINS UNIVERSITY (US) 2019-06-11 — — US disclosed
US-20160145305-A1 ENERGY TRANSFER WITHIN PI-CONJUGATED PEPTIDE HETEROSTRUCTURES IN AQUEOUS ENVIRONMENTS THE JOHNS HOPKINS UNIVERSITY (US) 2016-05-26 — — US disclosed
US-20160145305-A1 ENERGY TRANSFER WITHIN PI-CONJUGATED PEPTIDE HETEROSTRUCTURES IN AQUEOUS ENVIRONMENTS THE JOHNS HOPKINS UNIVERSITY (US) 2016-05-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160145305-A1 ENERGY TRANSFER WITHIN PI-CONJUGATED PEPTIDE HETEROSTRUCTURES IN AQUEOUS ENVIRONMENTS VIP, PITPNB, DCX TERT 1702/4885MEN1 1981/4885KMT2A 4781/4885
US-10316060-B2 Energy transfer within pi-conjugated peptide heterostructures in aqueous environments VIP, PITPNB, DCX TERT 1702/4885MEN1 1981/4885KMT2A 4781/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback